Top Markets
Coin of the day
Aida Pharmaceuticals, Inc. Aida Pharmaceuticals, Inc.

Aida Pharmaceuticals, Inc.

AIDA
Rangering i aksjer #41891
Aida Pharmaceuticals, Inc., together with its affiliates, operates extensively... Aida Pharmaceuticals, Inc., together with its affiliates, operates extensively throughout mainland China, specializing in the entire spectrum of pharmaceutical and genetic product development. This encompasses formulation, clinical trials, regulatory registration, manufacturing, sales, and marketing. The company's diverse product range includes antibiotics, cardiovascular medicines, and anti-cancer drugs. These are available in various forms, such as injectable powders, intravenous liquids, capsules, tablets, and ointments. Notable products feature Etimicin Sulfate, provided as an injectable powder, and rh-Apo2l, a biopharmaceutical therapy targeting cancers. Established in 1999, Aida Pharmaceuticals, Inc. is headquartered in Hangzhou, China.
Aksjekurs
$0.0003
Sist synkronisert: 2026-08-11
Markedsverdi
$8.10K
Endring (1 dag)
0.00%
Endring (1 år)
50.00%
Land
CN
Handel Aida Pharmaceuticals, Inc. (AIDA)

Kategori

Inntekter for Aida Pharmaceuticals, Inc. (AIDA)
Inntekter i 2026 TTM: 0
Ifølge Aida Pharmaceuticals, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Aida Pharmaceuticals, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter